Q. As a Sheffield resident I have never seen such strength of feeling as occurred during the City Council's debate regarding Palantir last week. With the exception of the Reform councillors, there was universal cross-party support for the resolution which the Council passed rejecting the Palantir contract.
In view of this, and of the overwhelming evidence that Palantir is a completely unsuitable company for the NHS to procure services from, will South Yorkshire Integrated Care Board now add its voice to the widespread demand that NHS England triggers the break clause in its existing contract?
A. We are aware of recent national debates in Parliament regarding the Federated Data Platform contract between NHS England and Palantir. We also acknowledge the recent concerns expressed in a Sheffield City Council meeting.
NHS South Yorkshire ICB owns and maintains its own secure data platform in addition to the FDP. This platform is used to undertake analysis of data to support commissioning and evaluation of services for patients. The ICB’s area within the FDP only contains data that is collected nationally by NHS England such as healthcare planning and commissioning of services and national statistics. The ICB is not flowing any locally-collected datasets (including General Practice data) into the FDP.
Each NHS organisation has its own secure area (referred to as an ‘instance’) within the platform. Only when the right permissions, legal requirements and approvals are in place can data be shared between these segregated areas. This means that each NHS organisation maintains control of its own data, but can collaborate when it is lawful, safe and beneficial for patients.
The use of the FDP within South Yorkshire is a matter for individual NHS provider organisations working closely with their regional and national colleagues and guidance.
We have added the FDP to our ICB risk register and will continue to review utilisation of the FDP in line with the national and regional position.
More information and FAQs are on the NHS FDP at NHS South Yorkshire ICB is available on the website.
Q. On 24th June 2026, Sheffield City Council passed a motion opposing the use of Palantir's Federated Data Platform, citing concerns over public trust, data sovereignty, and procurement ethics. The motion calls on the ICB and local NHS trusts to freeze integration with the platform and transition to a UK-based solution. As a patient of the NHS in Sheffield I concur with the concerns raised about Palantir’s integration within the NHS raised in the Council motion.
Given the previous ICB position that the use of the FDP is a 'matter for the NHS organisations’, but in light of Greater Manchester ICB continuing to choose to defer the adoption of the platform as it still doesn’t see it being in the ‘best interest of the Manchester population’, indicating that adoption of the FDP is not mandatory, can the Board confirm whether it will take the Council's motion on board and review its current position on the FDP in line with the concerns raised by the Council?
Sources for the points made in the question are:
https://www.theregister.com/software/2025/11/20/manchester-defers-joining-palantir-nhs-data-platform-again/1903254
and
https://www.youtube.com/watch?v=dBocO3x_Qrs
A. We are aware of recent national debates in Parliament regarding the Federated Data Platform contract between NHS England and Palantir. We also acknowledge the recent concerns expressed in a Sheffield City Council meeting.
NHS South Yorkshire ICB owns and maintains its own secure data platform in addition to the FDP. This platform is used to undertake analysis of data to support commissioning and evaluation of services for patients. The ICB’s area within the FDP only contains data that is collected nationally by NHS England such as healthcare planning and commissioning of services and national statistics. The ICB is not flowing any locally-collected datasets (including General Practice data) into the FDP.
Each NHS organisation has its own secure area (referred to as an ‘instance’) within the platform. Only when the right permissions, legal requirements and approvals are in place can data be shared between these segregated areas. This means that each NHS organisation maintains control of its own data, but can collaborate when it is lawful, safe and beneficial for patients.
The use of the FDP within South Yorkshire is a matter for individual NHS provider organisations working closely with their regional and national colleagues and guidance.
We have added the FDP to our ICB risk register and will continue to review utilisation of the FDP in line with the national and regional position.
More information and FAQs are on the NHS FDP at NHS South Yorkshire ICB is available on the website.
Q. It also raises the prospect of serious legal, financial and individual repercussions as has already been shown in the UK procurement and pensions sectors.
Therefore could you answer the following :-
a) Has any risk assessment been done on those legal and financial repercussions, if so, can you email me the documentation?
b) Your current intentions for the adoption of Palantir technologies in the Trusts of South Yorkshire?
c) As the some Trusts, such as Rotherham have adopted various Palantir technologies. Could you provide evidence on their efficacy or otherwise along with the various costs associated with its adoption and use on a per roll-out and per Trust basis?
d) Has there been any substantive attempts by any of the local Councils, their committees or individual members to stop the adoption of Palantir technologies in the Trusts of South Yorkshire, if so could you name them and provide the evidence?
e) Could we arrange a meeting with the Chair and involved officers to listen to our concerns and email me directly with some prospective times/dates?
A. We are aware of recent national debates in Parliament regarding the Federated Data Platform contract between NHS England and Palantir. We also acknowledge the recent concerns expressed in a Sheffield City Council meeting.
NHS South Yorkshire ICB owns and maintains its own secure data platform in addition to the FDP. This platform is used to undertake analysis of data to support commissioning and evaluation of services for patients. The ICB’s area within the FDP only contains data that is collected nationally by NHS England such as healthcare planning and commissioning of services and national statistics. The ICB is not flowing any locally-collected datasets (including General Practice data) into the FDP.
Each NHS organisation has its own secure area (referred to as an ‘instance’) within the platform. Only when the right permissions, legal requirements and approvals are in place can data be shared between these segregated areas. This means that each NHS organisation maintains control of its own data, but can collaborate when it is lawful, safe and beneficial for patients.
The use of the FDP within South Yorkshire is a matter for individual NHS provider organisations working closely with their regional and national colleagues and guidance.
We have added the FDP to our ICB risk register and will continue to review utilisation of the FDP in line with the national and regional position.
More information and FAQs are on the NHS FDP at NHS South Yorkshire ICB is available on the website.
NHS South Yorkshire are currently going through a period of organisational change and don’t currently have the capacity to meet with third parties regarding this matter at the moment.
Q. The board has previously stated that no patient data currently enters Palantir's Federated Data Platform; however, it has signalled intent to adopt the System Co-ordination Centre, which claims to provide insights through real time data ingestions. Can the ICB provide a timeline for when local patient data is due to enter the FDP, and are there intents to reassess this data integration following Sheffield City Council's recent motion calling on local NHS institutions to pause integration with Palantir's FDP?
Additionally, given the ICB does not intend to inform GP practices of when patient data will be extracted to the FDP, as mentioned in a recent Health and Wellbeing Board meeting, can the ICB reassure GP practices that as data controllers, if they were to update their data sharing agreements with the ICB, as has been recommended by the British Medical Association, so that explicit consent is sought prior to data sharing for the FDP - these updated agreements will be respected?
A. We are aware of recent national debates in Parliament regarding the Federated Data Platform contract between NHS England and Palantir. We also acknowledge the recent concerns expressed in a Sheffield City Council meeting.
NHS South Yorkshire ICB owns and maintains its own secure data platform in addition to the FDP. This platform is used to undertake analysis of data to support commissioning and evaluation of services for patients. The ICB’s area within the FDP only contains data that is collected nationally by NHS England such as healthcare planning and commissioning of services and national statistics. The ICB is not flowing any locally-collected datasets (including General Practice data) into the FDP.
Each NHS organisation has its own secure area (referred to as an ‘instance’) within the platform. Only when the right permissions, legal requirements and approvals are in place can data be shared between these segregated areas. This means that each NHS organisation maintains control of its own data, but can collaborate when it is lawful, safe and beneficial for patients.
The use of the FDP within South Yorkshire is a matter for individual NHS provider organisations working closely with their regional and national colleagues and guidance.
We can offer assurance to GP practices that we cannot share and do not intend to share data extracted from GP records into the FDP. This would have to be agreed via updating Data Sharing Agreements with each practice.
We have added the FDP to our ICB risk register and will continue to review utilisation of the FDP in line with the national and regional position.
More information and FAQs are on the NHS FDP at NHS South Yorkshire ICB is available on the website.
Q. In the context of a £48.9 million deficit and a £118 million underlying financial gap, and recognising that dressing products account for only around 6% of total wound care costs, with the vast majority driven by clinical time, particularly in the community. Would the Board support a commitment to actively explore and pilot value-based partnerships with MedTech providers to reduce unhealed wounds, release community nursing capacity, and deliver measurable system savings aligned to our neighbourhood care strategy?
A. In line with the ICB’s working with industry policy, we would open to exploring ways to work with industry to further our strategic aims through our medicines optimisation team.